Abbott logo

Abbott

Life-changing health technologies in the area of diagnostics, medical devices, nutritionals and branded generic medicines

152808 employees · est. 1944 · United States

VS
Immunic Therapeutics logo

Immunic Therapeutics

Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases

91 employees · est. 2016 · United States

Abbott is the older company (1944 vs 2016); Abbott is the larger of the two.

Side-by-Side Comparison

Abbott Immunic Therapeutics
Founded
1944 older 2016
Headquarters
United States United States
Employees
152808 larger 91
Industry
Biotechnology, Health Care, Manufacturing Biotechnology, Health and Wellness, Life Sciences
Funding Stage
IPO Post Ipo Equity
Total Funding
$6.80M $520.00M
Funding Rounds
3 10
Services
Pharmaceutical Products, Nutritional Products, Medical Devices, Diagnostic Solutions Not tracked yet
Target Customers
Urban Populations, Rural Communities, Healthcare Professionals, Infants and Young Children, Elderly Population Not tracked yet
Taxonomy
Diagnostics, Nutritionals, Branded Generic Medicines, HIV Treatment, Thyroid Hormone Therapy, Anticonvulsant Drugs, Rheumatoid Arthritis Treatment, Psoriatic Arthritis Treatment, Ankylosing Spondylitis Treatment, Global Healthcare Leader, Life-changing Technologies, Diversity In Workforce, Equal Opportunity Employer Small Molecule Therapies, Chronic Inflammatory Diseases, Autoimmune Diseases, Clinical Pipeline, Oral Administration, Nasdaq Listed, Drug Development, Precision Medicine, Pharmaceuticals, Immunology, Autoimmune Disorders
Website
abbott.com imux.com
Abbott logo

About Abbott

Abbott, founded in 1944, stands as a venerable leader in the global healthcare sector. With a diverse portfolio that spans diagnostics, medical devices, nutritionals, and branded generic medicines, Abbott operates in more than 160 countries, supported by a workforce exceeding 122,000 professionals....

Immunic Therapeutics logo

About Immunic Therapeutics

Immunic Therapeutics is a biotechnology company founded in 2016 and headquartered in the United States. The company's focus lies in the development of small molecule therapies for chronic inflammatory and autoimmune diseases. Immunic, listed on Nasdaq under the ticker symbol IMUX, boasts a clinical...

We will tell you when either one moves

BounceWatch watches Abbott and Immunic Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Abbott and Immunic Therapeutics — by email.

Frequently Asked Questions

Abbott — Life-changing health technologies in the area of diagnostics, medical devices, nutritionals and branded generic medicines. Immunic Therapeutics — Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Abbott has raised $6.80M while Immunic Therapeutics has raised $520.00M.
Abbott and Immunic Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Abbott with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Abbott on 15 Sep 2026, and Immunic Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes